Company
PAM Theragnostics GmbH
We develop strategies to strengthen the vascular system to slow down and potentially prevent AD onset.
Also known as PAM Theragnostics
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Hennigsdorf, Germany
- Founded
- 2020
- Legal name
- PAM Theragnostics GmbH
Claim, correct or request removal
Record updated 28 September 2026
About
Established in 2020, we are a biotech startup dedicated to developing the diagnostic tools and therapeutic strategies, aiming to detect early signs of age-related pathologies of the vascular systems, with the focus on Alzheimer's disease, and offer effective interventions to slow their progression. Currently, we are initiating GMP production and anticipate reaching our First-In-Human phase by 2027.
Funding snapshot
- Latest round
- Undisclosed2022-01-18
Funding rounds
- Round, 2022
- 2022-01-18
Loading relationship preview